Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» D.C. Vaccine Conference: Why Investors Should Stay Tuned
D.C. Vaccine Conference: Why Investors Should Stay Tuned
D.C. Vaccine Conference: Why Investors Should Stay Tuned
Submitted by
admin
on November 9, 2009 - 10:07am
Source:
Seeking Alpha
News Tags:
vaccines
Abbott Laboratories
Merck
Novartis
Sanofi Pasteur
Cel-Sci
Ibis
EpiVax
Immunovaccine
Advaxis
Headline:
D.C. Vaccine Conference: Why Investors Should Stay Tuned
Do Not Allow Advertisers to Use My Personal information